Although in vivo data and more detailed mechanisms are still absent from the present study, our data provide further insights into the anti-tumor effects of Gli in HCC cells, and proposes that Gli may be used as a new anticancer drug for HCC. This evidence concerns the gene GLI1 and hepatocellular carcinoma.